Acne Killer Genomma Tumbles After Report Former Unit Probed

  • Shares decline by most in eight months in Mexico City
  • Newspaper columnist says Marzam, Nadro under investigation

Genomma Lab Internacional SAB, the Mexican seller of remedies for acne and baldness, fell the most in eight months after a news report that a drug distributor in which the company sold a majority stake last year is being probed by antitrust regulators.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.